
Bioorganic and Medicinal Chemistry Letters p. 875 - 880 (1999)
Update date:2022-08-05
Topics:
Nishi, Takahide
Fukazawa, Tetsuya
Ishibashi, Koki
Nakajima, Katsuyoshi
Sugioka, Yuki
Iio, Yukiko
Kurata, Hitoshi
Itoh, Kazuhiro
Mukaiyama, Osamu
Satoh, Yumiko
Yamaguchi, Takeshi
We report herein the synthesis and structure-activity relationships of a series of novel oxazolidine analogues with regards to NK1 and NK2 tachykinin receptor binding affinity. Among this series of oxazolidine analogues, some compounds exhibited excellent high binding affinities for both NK1 and NK2 receptors. In addition, we describe the inhibitory effect in vivo on SP-induced airway vascular hyperpermeability and NKA-induced bronchoconstriction in guinea pigs.
View MoreShenyang Xinyihan Chemical Technology Co., Ltd.
Contact:+86-18525026267
Address:362, aigongbeijei street 23 , tiexi district,Shenyang, Liaoning, China
Contact:0086-29-89196322
Address:North of the Fifth Keji Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
Shenzhen JYMed Technology Co.,Ltd.
website:http://www.jymedtech.com
Contact:+86-755-26612112
Address:1#8,9/F, Biomedicine innovation Industrial Park, No.14, Jinhui Road, Pingshan Sistrict, Shenzhen, China
Tianjin Crest Pharmaceutical R&D Co., Ltd. (Tianjin Yao Technology Development Co., Ltd.)(expird)
Contact:+86-22-66211386
Address:Building B5-405, No, 80 4th Avenue, TEDA, Tianjin, China P.R. 300457
Yangzhou Siyu Chemical Co.,Ltd.
Contact:+86-514-87325867 13358126196
Address:Room 620 Exposition Pavilion,No. 98 Huaihai Road,Guangling District,Yangzhou City, Jiangsu Province
Doi:10.1007/s00044-018-2249-y
(2018)Doi:10.1039/c8ob00477c
(2018)Doi:10.1139/v69-054
(1969)Doi:10.1016/S0277-5387(96)00564-5
(1997)Doi:10.1002/zaac.201000444
(2011)Doi:10.1021/jo061515x
(2007)